Science & Research
New Initiative Aims to Improve Surgical Outcomes for Hemorrhagic Stroke Patients
The American Heart Association launches a nationwide initiative to standardize and improve surgical treatments for hemorrhagic strokes, which are responsible for over 40% of stroke-related deaths despite accounting for only 13% of cases.
Sino Biological Introduces ProPure™ Endotoxin-Free Proteins, Enhancing Research and Therapeutic Development
Sino Biological US, Inc. launches ProPure™, a line of ultra-pure, endotoxin-free recombinant proteins produced in the USA, setting a new industry standard for research and therapeutic applications.
New Study Reveals Hidden Chemical Threats Are Reshaping Ecosystems
A groundbreaking study highlights the complex, nonlinear impacts of chemical pollution on ecosystems, proposing a new framework for early detection and prevention of irreversible damage.
ESGold Corp. Reveals District-Scale Mineralization Potential at Montauban Project
ESGold Corp.'s recent survey at the Montauban Project in Quebec uncovers deep geological structures indicating significant mineralization potential, marking a pivotal step in exploration.
Calidi Biotherapeutics Featured in NetworkNewsWire Spotlight on Genetic Medicines
Calidi Biotherapeutics' innovative approach to treating hard-to-treat cancers with engineered viruses is highlighted in a NetworkNewsWire editorial, showcasing its potential to transform cancer treatment and address autoimmune disorders.
SeaStar Medical's QUELIMMUNE Recognized by National Kidney Foundation for Innovation in Pediatric AKI Treatment
SeaStar Medical's QUELIMMUNE device, designed to treat pediatric acute kidney injury, has been awarded the 2025 Corporate Innovator Award by the National Kidney Foundation, highlighting its potential to significantly reduce mortality rates and improve quality of life for affected children.
Global Ocean Analysis Offers Cost-Effective Alternative for Seafloor Positioning
A study finds that global ocean analysis products can replace expensive in-situ sound speed measurements for precise seafloor positioning, potentially reducing costs and logistical challenges in marine geodetic surveys.
Creative Biolabs Advances ADC Therapy with Precision Toxin Design and Pharmacokinetic Analysis
Creative Biolabs highlights the intricate balance and design behind ADC therapy, emphasizing the importance of toxin precision and pharmacokinetic studies for effective cancer treatment.
Study Links Traumatic Brain Injuries to Increased Brain Cancer Risk in Veterans
A recent study published in JAMA Network reveals that military veterans with traumatic brain injuries face a significantly higher risk of developing brain cancer, highlighting the urgent need for advanced treatments and preventive measures.
Fifty 1 Labs and UAV Corp Complete Historic REVIVE Trial, Pioneering Long COVID Treatment
Fifty 1 Labs, Inc. and UAV Corp have successfully completed the REVIVE Adaptive Platform Trial, marking a significant advancement in the treatment of Long COVID and positioning the companies for growth in the functional medicine market.
Aston Bay Holdings Reports Promising Initial Results from Storm Copper Project
Aston Bay Holdings Ltd. announces encouraging preliminary drill and geophysical results from its Storm Copper Project in Nunavut, highlighting the potential for significant copper mineralization.
Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Intelligent Bio Solutions Inc. will present its pharmacokinetic study data at the ADLM 2025 Clinical Lab Expo, highlighting the reliability of fingerprint sweat as a non-invasive diagnostic tool for drug screening.
Jupiter Neurosciences Advances in Treating Neuroinflammation and Aging with JOTROL™ and Nugevia™
Jupiter Neurosciences Inc. is making strides in treating central nervous system disorders and tapping into the longevity market with its innovative products JOTROL™ and Nugevia™, highlighting the potential to combat aging and neuroinflammation.
CNS Pharmaceuticals Inc. Showcases Lead Cancer Treatment Program in Virtual CEO Segment
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) emphasizes its lead cancer treatment program during a virtual CEO segment, highlighting potential advancements in brain and central nervous system cancer therapies.
Creative Biolabs Enhances Drug Delivery with LipoDrive™ Platform
Creative Biolabs introduces the LipoDrive™ platform, a cutting-edge solution for liposomal drug delivery, addressing the growing demand for precision in biopharmaceutical formulations.
New Study Links Cannabis Use to Enhanced Sexual Desire and Reduced Anxiety
Recent research indicates cannabis use may increase sexual interest and arousal while decreasing anxiety related to sexual activity, highlighting potential benefits of marijuana products.
Ninth Annual New York City Math Festival to Illuminate Fosun Plaza with Interactive Learning
The National Museum of Mathematics (MoMath) and Fosun will host the ninth annual New York City Math Festival, offering free, family-friendly activities that highlight the fun and importance of mathematics.
University of Sydney Researchers Discover Potential Breakthrough in Parkinson's Treatment
A preclinical study by University of Sydney researchers has successfully reversed Parkinson's-like symptoms in mice by targeting a malfunctioning protein, offering hope for future human treatments.
Quantum BioPharma Submits MS Drug Candidate to UK's ILAP Program
Quantum BioPharma Ltd. advances its multiple sclerosis treatment, Lucid-MS, through the UK's Innovative Licensing and Access Pathway, aiming to accelerate patient access to this innovative therapy.
Calidi Biotherapeutics' Genetic Medicine Platform Featured in Editorial for Cancer Treatment Innovation
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been highlighted in an editorial for its precision genetic medicine platform, offering a novel approach to targeting cancer tumors amidst rising global diagnoses.
Calidi Biotherapeutics' Genetic Medicine Platform Highlighted for Potential Cancer Breakthrough
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been featured in an editorial for its precision genetic medicine platform, which could revolutionize cancer treatment by targeting tumors with engineered viruses.
NeuroEyeCoach Study Highlights Benefits for Vision Rehabilitation in Home and Clinic Settings
A new study on NovaVision's NeuroEyeCoach demonstrates significant improvements in visual search performance for patients, whether used at home or in a clinic, supporting its role in vision rehabilitation.
Study Reveals Environmental Contaminant 6-PPDQ Disrupts Citric Acid Cycle in C. elegans
Research highlights the potential environmental and human health risks posed by 6-PPDQ, a contaminant derived from tire antioxidants, through its disruption of the citric acid cycle in C. elegans.
Benova Mouth Rinse Study Shows Significant Reduction in Inflammatory Marker TNF-Alpha
A recent study presented at the 2025 Diabetic Limb Salvage Conference reveals the Benova Mouth Rinse System's ability to reduce TNF-alpha, a key inflammatory marker, by 17% within two minutes, offering potential relief for millions suffering from oral inflammatory conditions.
Clene Inc. Advances Neurofilament Biomarker Analysis for CNM-Au8 in ALS with FDA Support
Clene Inc. is set to conduct a neurofilament biomarker analysis for CNM-Au8 in ALS patients, following constructive FDA feedback, aiming to support an accelerated approval submission in 2025.
Study Reveals Grapes May Enhance Skin's Resistance to UV Damage
Recent research highlights the potential of grapes to protect skin from UV damage, offering a natural approach to sun care alongside traditional methods.
Precision Genetic Medicine Platform Offers New Hope in Cancer Treatment
Calidi Biotherapeutics Inc. is pioneering a novel approach to cancer treatment with its precision genetic medicine platform, targeting both primary tumors and metastatic sites, potentially transforming cancer care and addressing other unmet medical needs.
Tonix Pharmaceuticals to Showcase TNX-801 Mpox Vaccine Data at Vaccine Congress 2025
Tonix Pharmaceuticals will present preclinical data on its TNX-801 mpox vaccine candidate at the Vaccine Congress 2025, highlighting its potential to address public health threats.
Silo Pharma Inc. Anticipates Key Study Results for PTSD Treatment SPC-15
Silo Pharma Inc. is on the verge of receiving crucial preclinical study results for SPC-15, a potential breakthrough in PTSD treatment, marking a significant step towards addressing a long-unmet medical need.
EHCO1: A New Era of Non-Sentient Superintelligence Unveiled by EHCOnomics
EHCOnomics introduces EHCO1, a groundbreaking non-sentient superintelligence that operates independently of traditional funding, cloud infrastructure, and pre-trained models, marking a significant shift in how intelligence is structured and applied.